What is Atb Cap Markets’ Estimate for Jushi Q1 Earnings?

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Analysts at Atb Cap Markets issued their Q1 2025 earnings estimates for Jushi in a research note issued to investors on Sunday, March 9th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.07) per share for the quarter. Atb Cap Markets currently has a “Strong Sell” rating on the stock. The consensus estimate for Jushi’s current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi’s Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.25) EPS, FY2026 earnings at ($0.20) EPS, FY2027 earnings at ($0.16) EPS and FY2028 earnings at ($0.12) EPS.

Jushi Stock Down 3.1 %

Shares of JUSHF stock opened at $0.28 on Wednesday. The firm has a market cap of $54.07 million, a price-to-earnings ratio of -1.02 and a beta of -0.83. The company’s 50 day moving average is $0.32 and its 200 day moving average is $0.39. Jushi has a 52-week low of $0.22 and a 52-week high of $0.92.

Jushi (OTCMKTS:JUSHF) last posted its quarterly earnings results on Wednesday, March 12th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The firm had revenue of $65.86 million for the quarter, compared to analysts’ expectations of $64.03 million.

Jushi Company Profile

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.